Stay updated on ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.

Latest updates to the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.6.4, replacing Revision: v3.6.3. This reflects a minor update to the page template or rendering.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays Revision: v3.6.3, indicating a new version of the page. This typically accompanies minor content or metadata updates rather than changes to the trial data.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page revision tag changed to v3.6.2, indicating a minor maintenance update to the page.SummaryDifference0.1%

- Check44 days agoChange DetectedRecruitment status is updated to indicate no new enrollments for this study. The update also adds a few navigation/label changes and a revision note (v3.6.0), including new sections like 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' while standardizing the 'Intervention/Treatment' heading.SummaryDifference0.4%

- Check51 days agoChange DetectedThe page shows a new revision label, v3.5.5, replacing the prior v3.5.4. This indicates a different published version of the page, likely an administrative update rather than a substantive change to study details.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page footer now shows revision v3.5.4 instead of v3.5.3. This signals an update to the site's documentation version rather than any study details.SummaryDifference0.1%

Stay in the know with updates to ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.